RESEARCH-USE BIOSIMILAR ANTIBODY

Tesidolumab

Monoclonal antibody · IgG1

C5IgG1RUO

Tesidolumab (LFG316) is a fully-human IgG1/λ anti-C5 monoclonal antibody of 143 kDa (without glycosylation). Tesidolumab (LFG316) blocks cleavage of C5 and prevents subsequent formation of the membrane attack complex.

TARGETC5
YMonoclonal antibody
CATALOGSC-BS-110
CATALOG NUMBERSC-BS-110
MOLECULAR WEIGHTApprox. 142.92 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Tesidolumab (LFG316) is a fully-human IgG1/λ anti-C5 monoclonal antibody of 143 kDa (without glycosylation). Tesidolumab (LFG316) blocks cleavage of C5 and prevents subsequent formation of the membrane attack complex.

Tesidolumab is a recombinant research-use antibody directed against C5.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte